NASDAQ:TYHT Shineco (TYHT) Stock Price, News & Analysis → Mysterious Gold Leverage Just Announced (From Stansberry Research) (Ad) Free TYHT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$6.13▼$12.7552-Week Range N/AVolume3,062 shsAverage Volume464,215 shsMarket Capitalization$97.24 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Shineco alerts: Email Address Ad Stansberry ResearchSee this before next week's Fed meetingSee this before next week's Fed Meeting Doc Eifrig just released a new video detailing "the perilous moment Americans are in right now." Angry voters, mounting government debt, and blood in the streets… But he's got a way out – a unique way to come out on top no matter who wins this presidential election. (Last time we shared this, it led to a 995% gain.) Click here to see it. About Shineco Stock (NASDAQ:TYHT)Shineco, Inc. is a holding company, which through its subsidiaries, engages in the production and distribution of plant-based products. It operates through the following segments: Luobuma Products, Herbal Products, and Other Agricultural Products. The Luobuma Products segment focuses in the development, manufacture, and distribution of specialized fabrics, textile products, and other by-products derived from an indigenous Chinese plant called Apocynum Venetum. The Herbal Products segment involves in the processing and distribution of traditional Chinese medicinal herbal products as well as other pharmaceutical products. The Other Agricultural Products segment comprises planting, processing, and distribution of green and organic agricultural produce and growing and cultivating of Chinese Yew trees. The company was founded on August 20, 1997 and is headquartered in Beijing, China.Read More Ad Stansberry ResearchSee this before next week's Fed meetingSee this before next week's Fed Meeting Doc Eifrig just released a new video detailing "the perilous moment Americans are in right now." Angry voters, mounting government debt, and blood in the streets… But he's got a way out – a unique way to come out on top no matter who wins this presidential election. (Last time we shared this, it led to a 995% gain.) Click here to see it. TYHT Stock News HeadlinesFebruary 22, 2024 | benzinga.comShineco Stock (NASDAQ:SISI) Earnings Dates and Earning CallsFebruary 15, 2024 | benzinga.comShineco Stock (NASDAQ:SISI) Dividends: History, Yield and DatesApril 25, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItSee this before next week's Fed Meeting Thousands of investing ideas come across his desk every year… But Doc Eifrig just revealed THIS ONE "will go down as one of the smartest and most lucrative financial moves of the decade." (Last time we shared this, it led to a 995% gain.)February 3, 2024 | investing.comAslan Pharmaceuticals Ltd ADR (ASLN)November 17, 2023 | markets.businessinsider.comShineco Announces the Appointment of Two New Executive OfficersOctober 30, 2023 | finance.yahoo.comShineco Opens Healthy Food Restaurant with Focus on Advanced NutritionAugust 25, 2023 | finance.yahoo.comShineco (SISI): A Hidden Gem or a Value Trap?July 10, 2023 | finance.yahoo.comWhy Are Shineco Shares Trading Higher Today?April 25, 2024 | Stansberry Research (Ad)“Retirement Secret” Showed 995% Gain Last Time We Shared ItSee this before next week's Fed Meeting Thousands of investing ideas come across his desk every year… But Doc Eifrig just revealed THIS ONE "will go down as one of the smartest and most lucrative financial moves of the decade." (Last time we shared this, it led to a 995% gain.)July 10, 2023 | marketwatch.comShineco Shares Jump 33% on Approval for Cardiac TestJuly 10, 2023 | finance.yahoo.comShineco Subsidiary Receives Marketing Approval from China’s Regulatory Body for its Cardiac 5-Minute TestJanuary 9, 2023 | msn.comHow Is The Market Feeling About Shineco?December 7, 2022 | finance.yahoo.comShineco, Inc Subsidiary, Granted USPTO Patent and FDA Marketing Approval for Its In-situ Fecal Specimen Sampling DeviceOctober 26, 2022 | fool.comShineco, Inc. (NASDAQ: TYHT)October 25, 2022 | finance.yahoo.comShineco, Inc. to Acquire Controlling Equity Interest in Changzhou Biowin Pharmaceutical Co., Ltd to Step into Point-of-Care Testing IndustryJune 13, 2022 | marketscreener.comSHINECO, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) - Marketscreener.comJune 7, 2022 | uk.investing.comStocks That Hit 52-Week Lows On Monday By Benzinga - Investing.com UKApril 14, 2022 | finance.yahoo.comShineco, Inc. Announces Entering into a Securities Purchase Agreement with Gross Proceeds of US$2.2 Million - Yahoo FinanceMarch 28, 2022 | globenewswire.comShineco, Inc. Announces Board and Officer Changes - GlobeNewswireMarch 18, 2022 | globenewswire.comShineco, Inc. Plans to Introduce a Private Equity Fund to Help its Business Transition - GlobeNewswireMarch 14, 2022 | rttnews.comPre-market Movers: VOLT, TRQ, ENSV, SBTX, MGLD… - RTTNewsMarch 13, 2022 | finance.yahoo.comShineco, Inc. to Build Its First Tumor Classification Diagnosis and Treatment Center in Weifang City, Shandong Province - Yahoo FinanceMarch 3, 2022 | globenewswire.comShineco, Inc. Announces New Website Launch - GlobeNewswireFebruary 24, 2022 | benzinga.comShineco To Create Industry-University-Research-Medical Collaborative Platform For Psychological Rehabilitation Of Tumor Patients - BenzingaFebruary 24, 2022 | globenewswire.comShineco, Inc. to Create an Industry-University-Research-Medical Collaborative Platform for Psychological Rehabilitation of Tumor Patients - GlobeNewswireFebruary 17, 2022 | globenewswire.comShineco, Inc. Announces Strategic Alliance to Enhance the - GlobeNewswireFebruary 11, 2022 | marketscreener.comShineco : Amendment to Annual Report (Form 10-K/A) - marketscreener.comSee More Headlines Receive TYHT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shineco and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Agricultural Production - Crops Sub-IndustryN/A Current SymbolNASDAQ:TYHT CUSIPN/A CIK1300734 Webwww.tianyiluobuma.com Phone861087227366FaxN/AEmployees318Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,630,000.00 Net Margins-159.60% Pretax MarginN/A Return on Equity-37.00% Return on Assets-29.88% Debt Debt-to-Equity RatioN/A Current Ratio3.88 Quick Ratio3.71 Sales & Book Value Annual Sales$23.68 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$21.90 per share Price / BookN/AMiscellaneous Outstanding Shares8,768,000Free FloatN/AMarket Cap$97.24 million OptionableNot Optionable Beta1.96 7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed InvestorsAs the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.Get This Free Report Key ExecutivesJennifer ZhanChief Executive Officer & Executive DirectorSam WangChief Financial Officer & DirectorKey CompetitorsIO BiotechNASDAQ:IOBTVigil NeuroscienceNASDAQ:VIGLKORU Medical SystemsNASDAQ:KRMDAnixa BiosciencesNASDAQ:ANIXVaccitechNASDAQ:VACCView All Competitors TYHT Stock Analysis - Frequently Asked Questions When did Shineco's stock split? Shineco's stock reverse split on Monday, August 17th 2020. The 1-9 reverse split was announced on Thursday, August 13th 2020. The number of shares owned by shareholders was adjusted after the market closes on Friday, August 14th 2020. An investor that had 100 shares of stock prior to the reverse split would have 11 shares after the split. What other stocks do shareholders of Shineco own? Based on aggregate information from My MarketBeat watchlists, some companies that other Shineco investors own include SCYNEXIS (SCYX), Lockheed Martin (LMT), AbbVie (ABBV), Bausch Health Companies (BHC), Amicus Therapeutics (FOLD), NIO (NIO), Trevena (TRVN), Verastem (VSTM), Zynerba Pharmaceuticals (ZYNE) and AcelRx Pharmaceuticals (ACRX). This page (NASDAQ:TYHT) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap Profits“The Biggest Bubble of All Time” – Here’s What to Do.Chaikin Analyticstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyWill this $2 AI stock double overnight?Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shineco, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
